Cargando…
Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer
SIMPLE SUMMARY: Breast cancer is the most commonly diagnosed and second leading cause of cancer-related deaths in women in the United States, with hormone receptor positive (HR+) tumors representing more than two-thirds of new cases. Recent evidence has indicated that dysregulation of multiple metab...
Autores principales: | Hussein, Shaimaa, Khanna, Pooja, Yunus, Neha, Gatza, Michael L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508306/ https://www.ncbi.nlm.nih.gov/pubmed/34638293 http://dx.doi.org/10.3390/cancers13194808 |
Ejemplares similares
-
CPT1A and fatty acid β-oxidation are essential for tumor cell growth and survival in hormone receptor-positive breast cancer
por: Jariwala, Nidhi, et al.
Publicado: (2021) -
The nuclear receptor Hr46/Hr3 is required in the blood brain barrier of mature males for courtship
por: Lama, Chamala, et al.
Publicado: (2022) -
Integrative proteogenomic analyses of human tumours identifies ADNP as a novel oncogenic mediator of cell cycle progression in high-grade serous ovarian cancer with poor prognosis
por: Karagoz, Kubra, et al.
Publicado: (2019) -
Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC
por: Iwase, Toshiaki, et al.
Publicado: (2020) -
Editorial: Metabolic reprogramming in breast cancer
por: Scatena, Cristian, et al.
Publicado: (2022)